[Federal Register Volume 70, Number 13 (Friday, January 21, 2005)]
[Notices]
[Page 3204]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-1135]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public.

DATES: The meeting will be held on February 8, 2005, from 9 a.m. to 4 
p.m., and on February 9, 2005, from 9 a.m. to 4 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION, CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, Room 725H Hubert H. Humphrey Building, 200 Independence 
Avenue, SW., Washington, DC 20201; (202) 690-5566, 
[email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Service Act (42 U.S.C. 300aa-1), the Secretary of Health and Human 
Services was mandated to establish the National Vaccine Program to 
achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Assistant 
Secretary for Health, as the Director of the National Vaccine Program, 
on matters related to the program's responsibilities.
    Topics to be discussed at the meeting include influenza control, 
polio eradication and vaccine stockpiles, vaccine safety, and vaccine 
supply. Updates will be given on the NVAC Working Group on Public 
Participation, the NVAC Vaccine Safety and Communications Subcommittee, 
the NVAC Futures Vaccines Subcommittee, and the NVAC Immunization 
Coverage Subcommittee. A tentative agenda will be made available on or 
about January 25, 2005 for review on the NVAC Web site: http://www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to space available. 
Individuals must provide a photo ID for entry into the Humphrey 
Building. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact person. Members of 
the public will have the opportunity to provide comments at the 
meeting. Public comment will be limited to five minutes per speaker. 
Any members of the public who wish to have printed material distributed 
to NVAC members should submit materials to the Executive Secretary, 
NVAC, through the contact person listed above prior to close of 
business February 1, 2005. Preregistration is required for both public 
attendance and comment. Any individual who wishes to attend the meeting 
and/or participate in the public comment session should e-mail 
[email protected].

    Dated: January 12, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05-1135 Filed 1-19-05; 8:45 am]
BILLING CODE 4150-28-P